{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:18:22Z","timestamp":1759342702877,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:00:00Z","timestamp":1656028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10067-022-06246-4","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T00:32:37Z","timestamp":1656030757000},"page":"3143-3150","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk factors of urinary calculi in men with gout"],"prefix":"10.1007","volume":"41","author":[{"given":"Yu","family":"Cao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-7586","authenticated-orcid":false,"given":"Xuejun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"6246_CR1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/762820","volume":"2015","author":"R Liu","year":"2015","unstructured":"Liu R, Han C, Wu D et al (2015) Prevalence of hyperuricemia and gout in mainland China from 2000 to 2014: a systematic review and meta-analysis. Biomed Res Int 2015:762820. https:\/\/doi.org\/10.1155\/2015\/762820","journal-title":"Biomed Res Int"},{"key":"6246_CR2","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1016\/j.juro.2012.11.076","volume":"189","author":"T Shimizu","year":"2013","unstructured":"Shimizu T, Kitada H, Umeyama M et al (2013) Novel evaluation of nephrolithiasis as a complication of gout: a cross-sectional study using helical computerized tomography. J Urol 189:1747\u20131752. https:\/\/doi.org\/10.1016\/j.juro.2012.11.076","journal-title":"J Urol"},{"key":"6246_CR3","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1093\/rheumatology\/key096","volume":"57","author":"M Bevis","year":"2018","unstructured":"Bevis M, Blagojevic-Bucknall M, Mallen C et al (2018) Comorbidity clusters in people with gout: an observational cohort study with linked medical record review. Rheumatology (Oxford) 57:1358\u20131363. https:\/\/doi.org\/10.1093\/rheumatology\/key096","journal-title":"Rheumatology (Oxford)"},{"key":"6246_CR4","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/annrheumdis-2013-203779","volume":"74","author":"P Richette","year":"2015","unstructured":"Richette P, Clerson P, Perissin L et al (2015) Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis 74:142\u2013147. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203779","journal-title":"Ann Rheum Dis"},{"key":"6246_CR5","doi-asserted-by":"publisher","unstructured":"Wan KS, Liu CK, Ko MC, et al. (2016) Nephrolithiasis among male patients with newly diagnosed gout. Hong Kong Med J 22:534\u2013537. https:\/\/doi.org\/10.12809\/hkmj154694","DOI":"10.12809\/hkmj154694"},{"key":"6246_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027702","volume":"9","author":"S Qin","year":"2019","unstructured":"Qin S, Wang J, Zhou C et al (2019) The association between a non-invasive hepatic fibrosis score and urolithiasis among non-alcoholic fatty liver disease (NAFLD) patients in China: a cross-sectional study. BMJ Open 9:e027702. https:\/\/doi.org\/10.1136\/bmjopen-2018-027702","journal-title":"BMJ Open"},{"key":"6246_CR7","doi-asserted-by":"publisher","unstructured":"Zeng J, Wang S, Zhong L, et al. (2019) A retrospective study of kidney stone recurrence in adults. J Clin Med Res 11:208\u2013212. https:\/\/doi.org\/10.14740\/jocmr3753","DOI":"10.14740\/jocmr3753"},{"key":"6246_CR8","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.1002\/art.39254","volume":"67","author":"T Neogi","year":"2015","unstructured":"Neogi T, Jansen TL, Dalbeth N et al (2015) 2015 Gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol 67:2557\u20132568. https:\/\/doi.org\/10.1002\/art.39254","journal-title":"Arthritis Rheumatol"},{"key":"6246_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3321\/j.issn:0512-7955.2004.01.001","volume":"26","author":"Work Group on Obesity in China","year":"2004","unstructured":"Work Group on Obesity in China (2004) Guidelines for prevention and control of overweight and obesity in Chinese adults. Acta Nutrimenta Sinica 26:1\u20134. https:\/\/doi.org\/10.3321\/j.issn:0512-7955.2004.01.001","journal-title":"Acta Nutrimenta Sinica"},{"key":"6246_CR10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH et al (2009) A new equation to estimate glomerular filtration rate. Ann Intern Med 150:604\u2013612. https:\/\/doi.org\/10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"6246_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3904\/kjim.2016.062","volume":"33","author":"JH Jung","year":"2018","unstructured":"Jung JH, Song GG, Ji JD et al (2018) Metabolic syndrome: prevalence and risk factors in Korean gout patients. Korean J Intern Med 33:815\u2013822. https:\/\/doi.org\/10.3904\/kjim.2016.062","journal-title":"Korean J Intern Med"},{"key":"6246_CR12","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.amjmed.2011.09.033","volume":"125","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, Pandya BJ, Choi HK (2012) Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007\u20132008. Am J Med 125:679-687.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2011.09.033","journal-title":"Am J Med"},{"key":"6246_CR13","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1080\/15257770.2013.853785","volume":"33","author":"NM Gonz\u00e1lez-Senac","year":"2014","unstructured":"Gonz\u00e1lez-Senac NM, Bail\u00e9n R, Torres RJ et al (2014) Metabolic syndrome in primary gout. Nucleosides Nucleotides Nucleic Acids 33:185\u2013191. https:\/\/doi.org\/10.1080\/15257770.2013.853785","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"45","key":"6246_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008532","volume":"96","author":"F Sheng","year":"2017","unstructured":"Sheng F, Fang W, Zhang B et al (2017) Adherence to gout management recommendations of Chinese patients. Medicine 96(45):e8532. https:\/\/doi.org\/10.1097\/MD.0000000000008532","journal-title":"Medicine"},{"key":"6246_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-017-1376-z","volume":"19","author":"AJ Landgren","year":"2017","unstructured":"Landgren AJ, Jacobsson LTH, Lindstr\u00f6m U et al (2017) Incidence of and risk factors for nephrolithiasis in patients with gout and the general population, a cohort study. Arthritis Res Ther 19:173. https:\/\/doi.org\/10.1186\/s13075-017-1376-z","journal-title":"Arthritis Res Ther"},{"key":"6246_CR16","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s42358-019-0106-4","volume":"60","author":"LS Hoff","year":"2019","unstructured":"Hoff LS, Goldenstein-Schainberg C, Fuller R (2019) Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients. Adv Rheumatol 60:2. https:\/\/doi.org\/10.1186\/s42358-019-0106-4","journal-title":"Adv Rheumatol"},{"key":"6246_CR17","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1046\/j.1523-1755.2003.t01-2-00171.x","volume":"64","author":"HJ Kramer","year":"2003","unstructured":"Kramer HJ, Choi HK, Atkinson K et al (2003) The association between gout and nephrolithiasis in men: the health professionals\u2019 follow-up study. Kidney Int 64:1022\u20131026. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.t01-2-00171.x","journal-title":"Kidney Int"},{"key":"6246_CR18","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.3899\/jrheum.081128","volume":"36","author":"T Shimizu","year":"2009","unstructured":"Shimizu T, Hori H (2009) The prevalence of nephrolithiasis in patients with primary gout: a cross-sectional study using helical computed tomography. J Rheumatol 36:1958\u20131962. https:\/\/doi.org\/10.3899\/jrheum.081128","journal-title":"J Rheumatol"},{"key":"6246_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00240-009-0218-0","volume":"37","author":"YM Marickar","year":"2009","unstructured":"Marickar YM (2009) Calcium oxalate stone and gout. Urol Res 37:345\u2013347. https:\/\/doi.org\/10.1007\/s00240-009-0218-0","journal-title":"Urol Res"},{"key":"6246_CR20","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1093\/ndt\/gfr703","volume":"27","author":"K Sakhaee","year":"2012","unstructured":"Sakhaee K, Capolongo G, Maalouf NM et al (2012) Metabolic syndrome and the risk of calcium stones. Nephrol Dial Transplant 27:3201\u20133209. https:\/\/doi.org\/10.1093\/ndt\/gfr703","journal-title":"Nephrol Dial Transplant"},{"key":"6246_CR21","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1055\/s-2007-982517","volume":"39","author":"S Takahashi","year":"2007","unstructured":"Takahashi S, Inokuchi T, Kobayashi T et al (2007) Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH. Horm Metab Res 39:511\u2013514. https:\/\/doi.org\/10.1055\/s-2007-982517","journal-title":"Horm Metab Res"},{"key":"6246_CR22","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.kint.2018.11.024","volume":"95","author":"NM Maalouf","year":"2019","unstructured":"Maalouf NM, Poindexter JR, Adams-Huet B et al (2019) Increased production and reduced urinary buffering of acid in uric acid stone formers is ameliorated by pioglitazone. Kidney Int 95:1262\u20131268. https:\/\/doi.org\/10.1016\/j.kint.2018.11.024","journal-title":"Kidney Int"},{"key":"6246_CR23","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.ekir.2017.06.001","volume":"2","author":"X Fan","year":"2017","unstructured":"Fan X, Kalim S, Ye W et al (2017) urinary stone disease and cardiovascular disease risk in a rural Chinese population. Kidney Int Rep 2:1042\u20131049. https:\/\/doi.org\/10.1016\/j.ekir.2017.06.001","journal-title":"Kidney Int Rep"},{"key":"6246_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s00240-018-1082-6","volume":"47","author":"ACP de Freitas","year":"2019","unstructured":"de Freitas ACP, Torres LC, Duarte M et al (2019) Is oxidized low-density lipoprotein the connection between atherosclerosis, cardiovascular risk and nephrolithiasis? Urolithiasis 47:347\u2013356. https:\/\/doi.org\/10.1007\/s00240-018-1082-6","journal-title":"Urolithiasis"},{"key":"6246_CR25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1042\/cs20171574","volume":"132","author":"A Devarajan","year":"2018","unstructured":"Devarajan A (2018) Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases. Clin Sci (Lond) 132:615\u2013626. https:\/\/doi.org\/10.1042\/cs20171574","journal-title":"Clin Sci (Lond)"},{"key":"6246_CR26","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1097\/01.ju.0000120291.90839.49","volume":"171","author":"ML Stoller","year":"2004","unstructured":"Stoller ML, Meng MV, Abrahams HM et al (2004) The primary stone event: a new hypothesis involving a vascular etiology. J Urol 171:1920\u20131924. https:\/\/doi.org\/10.1097\/01.ju.0000120291.90839.49","journal-title":"J Urol"},{"issue":"1","key":"6246_CR27","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10067-021-05930-1","volume":"41","author":"TL Jansen","year":"2022","unstructured":"Jansen TL, Giesen T, Janssen M (2022) A historical journey of searching for uricosuric drugs. Clin Rheumatol. 41(1):297\u2013305. https:\/\/doi.org\/10.1007\/s10067-021-05930-1","journal-title":"Clin Rheumatol."}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-022-06246-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-022-06246-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T14:28:16Z","timestamp":1663597696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-022-06246-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["6246"],"URL":"https:\/\/doi.org\/10.1007\/s10067-022-06246-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}